GSK Jumps On Report Elliott Has Built Up Multibillion-Pound Stake In Firm



© Reuters.

By Dhirendra Tripathi

Investing.com – Shares of GlaxoSmithKline (NYSE:) were higher by 6% in Thursday’s premarket following a report by Financial Times that hedge fund Elliott Management has built up a multibillion-pound stake in the pharma giant.

The news has sent the shares soaring after three years under the stewardship of Emma Walmsley, in which the shares have steadily underperformed vis-a-vis major rivals such as AstraZeneca (NASDAQ:) and Pfizer (NYSE:) 

Walmsley last year unveiled plans to break up the company by separating the consumer health business from its pharma and vaccine division, which has failed to deliver in the race to find a treatment for Covid-19.

The FT didn’t report any details of what changes Elliott, known for its activism, might press for.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

READ  Ulta Beauty Earnings beat, Revenue misses In Q2





READ SOURCE

LEAVE A REPLY

Please enter your comment!
Please enter your name here